Afrodite Sialakouma1,2, Ioannis Karakasiliotis3, Vaia Ntala2, Nikolaos Nikolettos4, Byron Asimakopoulos2. 1. IVF Assisted Reproduction Unit, Mitera General Hospital, Athens, Greece; asialakouma@gmail.com. 2. Laboratory of Physiology, Faculty of Medicine, Democritus University of Thrace, Alexandroupolis, Greece. 3. Laboratory of Biology, Faculty of Medicine, Democritus University of Thrace, Alexandroupolis, Greece. 4. Gynecological Clinic, General University Hospital of Alexandroupolis, Democritus University of Thrace, Alexandroupolis, Greece.
Abstract
BACKGROUND/AIM: Preimplantation genetic testing (PGT) for chromosomal screening, based on embryo biopsy, has significant limitations. Cell-free DNA (cf-DNA) has been detected in spent culture medium (SCM), opening new horizons for the development of non-invasive PGT (ni-PGT). In this study, we evaluated the diagnostic performance of ni-PGT for aneuploidy (niPGT-A), comparing the results of trophectoderm biopsies (TE) and respective SCM from individually cultured embryos via Next Generation Sequencing (NGS). MATERIALS AND METHODS: Forty fresh embryos were analyzed. TE and SCM from blastocysts were collected and analyzed. RESULTS: We detected cfDNA in 100% of samples tested. The overall concordance rate between the ni-PGT-A and PGT-A was 27/33 (81.8%). The full concordance rate was 21/33 (63.6%). The aneuploidy agreement was 91.66%, and the euploidy agreement was 76.19%. CONCLUSION: We found a good accordance between TE and SCM analysis, suggesting that niPGT-A could be a reliable alternative for chromosomal abnormalities assessment of in vitro cultured embryos.
BACKGROUND/AIM: Preimplantation genetic testing (PGT) for chromosomal screening, based on embryo biopsy, has significant limitations. Cell-free DNA (cf-DNA) has been detected in spent culture medium (SCM), opening new horizons for the development of non-invasive PGT (ni-PGT). In this study, we evaluated the diagnostic performance of ni-PGT for aneuploidy (niPGT-A), comparing the results of trophectoderm biopsies (TE) and respective SCM from individually cultured embryos via Next Generation Sequencing (NGS). MATERIALS AND METHODS: Forty fresh embryos were analyzed. TE and SCM from blastocysts were collected and analyzed. RESULTS: We detected cfDNA in 100% of samples tested. The overall concordance rate between the ni-PGT-A and PGT-A was 27/33 (81.8%). The full concordance rate was 21/33 (63.6%). The aneuploidy agreement was 91.66%, and the euploidy agreement was 76.19%. CONCLUSION: We found a good accordance between TE and SCM analysis, suggesting that niPGT-A could be a reliable alternative for chromosomal abnormalities assessment of in vitro cultured embryos.
Authors: Sebastiaan Mastenbroek; Moniek Twisk; Jannie van Echten-Arends; Birgit Sikkema-Raddatz; Johanna C Korevaar; Harold R Verhoeve; Niels E A Vogel; Eus G J M Arts; Jan W A de Vries; Patrick M Bossuyt; Charles H C M Buys; Maas Jan Heineman; Sjoerd Repping; Fulco van der Veen Journal: N Engl J Med Date: 2007-07-04 Impact factor: 91.245
Authors: Jennifer R Gruhn; Agata P Zielinska; Vallari Shukla; Robert Blanshard; Antonio Capalbo; Danilo Cimadomo; Dmitry Nikiforov; Andrew Chi-Ho Chan; Louise J Newnham; Ivan Vogel; Catello Scarica; Marta Krapchev; Deborah Taylor; Stine Gry Kristensen; Junping Cheng; Erik Ernst; Anne-Mette Bay Bjørn; Lotte Berdiin Colmorn; Martyn Blayney; Kay Elder; Joanna Liss; Geraldine Hartshorne; Marie Louise Grøndahl; Laura Rienzi; Filippo Ubaldi; Rajiv McCoy; Krzysztof Lukaszuk; Claus Yding Andersen; Melina Schuh; Eva R Hoffmann Journal: Science Date: 2019-09-27 Impact factor: 47.728
Authors: Yang Yu; Yue Zhao; Rong Li; Li Li; Hongcui Zhao; Min Li; Jiahao Sha; Qi Zhou; Jie Qiao Journal: J Proteome Res Date: 2013-11-25 Impact factor: 4.466